Dr. Daniel S. Strand, MD

Dr. Strand practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Strand's NPI, 1003013210, was assigned on June 29, 2007. Dr. Strand graduated from University of Florida College of Medicine in 2007. Dr. Strand holds Virginia license 0101253643.

Dr. Strand's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Strand's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Strand is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Strand to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Strand practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Strand's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Strand is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Strand's licenses on file in 2 states: Virginia and Florida.

CMS data shows 701 Medicare services from Dr. Strand across 17 procedure codes in 2024, for 243 Medicare patients. Medicare paid $73,892 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 243 Medicare patients who saw Dr. Strand in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Strand's median patient age at 63, with 52% women.

In 2024, Dr. Strand wrote 283 Medicare Part D claims for 100 patients. 75% of them were for generic drugs. CMS names the drug for 204 of them, across 6 drugs with 11 or more claims each, at $175,684 in total drug cost. In 2023, CMS named 223 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Strand for performance year 2024, reported as part of a group. Dr. Strand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 492 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Strand, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 29 papers to Dr. Strand, published from 2012 to 2024. 2024 was the busiest year, with 6. The most frequent topics are Pancreatectomy, Pancreatic Neoplasms and Pancreatitis, Chronic. Dr. Strand has published most often in Gastrointest Endosc. Dr. Strand's most frequent co-authors are Victor M. Zaydfudim, MD, Reid B. Adams and Anuragh Reddy Gudur, MD.

Dmand AI links Dr. Strand to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 5 general payments to Dr. Strand from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Cook Medical LLC paid the most, $698.

Dr. Strand graduated from University of Florida College of Medicine in 2007.